Interaction between β-catenin and HIF-1 promotes cellular adaptation to hypoxia

Nature Cell Biology

Volumn 9, Issue 2, 2007, Pages 210-217

  Kaidi, Abderrahmane ^a   Williams, Ann Caroline ^a   Paraskeva, Christos ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MYC PROTEIN; PROTEIN P21; T CELL FACTOR PROTEIN; T CELL FACTOR PROTEIN 4; UNCLASSIFIED DRUG;

ADAPTATION; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL HYPOXIA; CELL PROLIFERATION; CELL STRAIN HCT116; CELL STRAIN HEK293; CELL SURVIVAL; CELLULAR DISTRIBUTION; COLON CARCINOGENESIS; COLORECTAL TUMOR; COMPLEX FORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DNA INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ADAPTATION, PHYSIOLOGICAL; ANOXIA; BETA CATENIN; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; COLONIC NEOPLASMS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; SIGNAL TRANSDUCTION;

EID: 33947217823     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncb1534     Document Type: Article

References (30)

1. van de Wetering, M. et al. The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111, 241-250 (2002).
2. Korinek, V. et al. Constitutive transcriptional activation by a β-catenin-Tcf complex in APC-colon carcinoma. Science 275, 1784-1787 (1997).
3. Morin, P. J. et al. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 275, 1787-1790 (1997).
4. Carmeliet, P. et al. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 394, 485-490 (1998).
5. Harris, A. L. Hypoxia - a key regulatory factor in tumour growth. Nature Rev. Cancer 2, 38-47 (2002).
6. Reya, T. & Clevers, H. Wnt signalling in stem cells and cancer. Nature 434, 843-850 (2005).
7. van de Wetering, M. et al. Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF. Cell 88, 789-799 (1997).
8. He, T. C. et al. Identification of c-MYC as a target of the APC pathway. Science 281, 1509-1512 (1998).
9. Hockel, M. & Vaupel, P. Tumor hypoxia: Definitions and current clinical, biologic, and molecular aspects. J. Natl Cancer Inst. 93, 266-276 (2001).
10. Maxwell, P. H. et al. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc. Natl Acad. Sci. USA 94, 8104-8109 (1997).
11. 2 Tension. Proc. Natl Acad. Sci. USA 92, 5510-5514 (1995).
12. Semenza, G. L. Targeting HIF-1 for cancer therapy. Nature Rev. Cancer 3, 721-732 (2003).
13. Lal, A. et al. Transcriptional response to hypoxia in human tumors. J. Natl Cancer Inst. 93, 1337-1343 (2001).
14. Rosin-Arbesfeld, R., Cliffe, A., Brabletz, T. & Bienz, M. Nuclear export of the APC tumour suppressor controls β-catenin function in transcription. EMBO J. 22, 1101-1113 (2003).
15. 2-regulated prolyl hydroxylation. Science 292, 468-472 (2001).
16. Mosimann, C., Hausmann, G. & Basler, K. Parafibromin/Hyrax activates Wnt/ Wg target gene transcription by direct association with β-catenin/ Armadillo. Cell 125, 327-341 (2006).
17. Kaidi, A., Qualtrough, D., Williams, A. C. & Paraskeva, C. Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia. Cancer Res. 66, 6683-6691 (2006).
18. van de Wetering, M. et al. Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep. 4, 609-615 (2003).
19. Zhong, H. et al. Overexpression of hypoxia-inducible factor 1 a in common human cancers and their metastases. Cancer Res. 59, 5830-5835 (1999).
20. Vaupel, P., Thews, O., Kelleher, D. K. & Hoeckel, M. Current status of knowledge and critical issues in tumor oxygenation. Results from 25 years research in tumor pathophysiology. Adv. Exp. Med. Biol. 454, 591-602 (1998).
21. Goethals, L. et al. Hypoxia in human colorectal adenocarcinoma: comparison between extrinsic and potential intrinsic hypoxia markers. Int. J. Radiat. Oncol. Biol. Phys. 65, 246-254 (2006).
22. Goda, N. et al. Hypoxia-inducible factor 1a is essential for cell cycle arrest during hypoxia. Mol. Cell Biol. 23, 359-369 (2003).
23. Kim, J. H. et al. Transcriptional regulation of a metastasis suppressor gene by Tip60 and β-catenin complexes. Nature 434, 921-926 (2005).
24. Essers, M. A. et al. Functional interaction between β-catenin and FOXO in oxidative stress signaling. Science 308, 1181-1184 (2005).
25. Giles, R. H. et al. Interplay between VHL/HIF1a and Wnt/β-catenin pathways during colorectal tumorigenesis. Oncagene 25, 3065-3070 (2006).
26. 2 homeostasis by hypoxia-inducible factor 1 α. Genes Dev 12, 149-162 (1998).
27. Maretto, S. et al. Mapping Wnt/β-catenin signaling during mouse development and in colorectal tumors. Proc. Natl Acad. Sci. USA 100, 3299-3304 (2003).
28. Chell, S. D. et al. Increased EP4 receptor expression in colorectal cancer progression promotes cell growth and anchorage independence. Cancer Res. 66, 3106-3113 (2006).
29. Elder, D. J., Hague, A., Hicks, D. J. & Paraskeva, C. Differential growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines: Enhanced apoptosis in carcinoma and in vitro-transformed adenoma relative to adenoma relative to adenoma cell lines. Cancer Res. 56, 2273-2276 (1996).
30. Essafi, A. et al. Direct transcriptional regulation of Bim by FoxO3a mediates STI571-induced apoptosis in Bcr-Abl-expressing cells. Oncogene 24, 2317-2329 (2005).